Cargando…
Methylation-based reclassification and risk stratification of skull-base chordomas
BACKGROUND: Skull-base chordomas are rare malignant bone cancers originating from the remnant of the notochord. Survival is variable, and clinical or molecular factors cannot reliably predict their outcomes. This study therefore identified epigenetic subtypes that defined new chordoma epigenetic pro...
Autores principales: | Huo, Xulei, Guo, Tengxian, Wang, Ke, Yao, Bohan, Li, Da, Li, Huan, Chen, Wei, Wang, Liang, Wu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691996/ https://www.ncbi.nlm.nih.gov/pubmed/36439461 http://dx.doi.org/10.3389/fonc.2022.960005 |
Ejemplares similares
-
Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma
por: Huo, Xulei, et al.
Publicado: (2023) -
The role of Gamma Knife radiosurgery in the management of skull base chordoma
por: Wang, Kuanyu, et al.
Publicado: (2023) -
High systemic inflammation score is associated with adverse survival in skull base chordoma
por: Li, Mingxuan, et al.
Publicado: (2022) -
PALB2 as a factor to predict the prognosis of patients with skull base chordoma
por: Xiong, Yujia, et al.
Publicado: (2022) -
Factors for tumor progression in patients with skull base chordoma
por: Wang, Liang, et al.
Publicado: (2016)